Substantial evidence supports the involvement of aberrant expression of Rho and elevated Rho activity in the metastasis capacity of different types of cancers such as breast, colon, prostate, lung, head and neck, and pancreatic cancers [5]–[8]. The gene discussed is RHO; the disease is cancer.